top of page

Fungi

FungiĀ are unicellular or multicellular eukaryotic organismsĀ found everywhere in nature. From large macroscopic species such as mushrooms and molds to microscopic yeasts, fungi exhibit remarkable morphological diversity.

While most fungi are harmless to humans, some can cause disease under specific conditions.

Image: ā€œHands of a woman with onychia mycosisā€ (watercolour, 1889) by Leonard Portal Mark. Courtesy of Barts Health NHS Trust Archives / Wellcome Images, original file ā€œHands_of_a_woman_with_onychia_mycosis_Wellcome_L0062076.jpgā€ on Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Hands_of_a_woman_with_onychia_mycosis_Wellcome_L0062076.jpg). Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).
Image: ā€œHands of a woman with onychia mycosisā€ (watercolour, 1889) by Leonard Portal Mark. Courtesy of Barts Health NHS Trust Archives / Wellcome Images, original file ā€œHands_of_a_woman_with_onychia_mycosis_Wellcome_L0062076.jpgā€ on Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Hands_of_a_woman_with_onychia_mycosis_Wellcome_L0062076.jpg). Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).

Public Health and Global Significance

Fungal infections kill over 1.5 million people each yearĀ and affect more than one billion globallyĀ [1][2]. Despite this, they remain a neglected public health issue, even though most deaths could be prevented with timely diagnosis and accessible treatment.

Severe fungal infections often occur as complications of underlying conditionsĀ such as:

  • Asthma

  • AIDS/HIV

  • Cancer

  • Organ transplantation

  • Immunosuppressive therapy


Transmission and Pathogenesis

  • Fungi reproduce through sporesĀ that spread via direct contact or inhalation.

  • Infections most commonly affect the skin, nails, and lungs, but fungi can also penetrate the skin barrier, invade organs, and cause systemic infectionsĀ [3].

  • Many fungal infections are chronic and difficult to treat, with invasive mycoses often requiring months to yearsĀ of therapy.


Unique Characteristics of Fungal Infections

  • Often chronicĀ and potentially fatalĀ if untreated.

  • Low contagion rateĀ compared to bacterial or viral diseases, which contributes to limited public health awarenessĀ [4].

  • Certain chronic infections, such as chromoblastomycosisĀ and eumycetoma, can cause disfigurement, social isolation, and functional impairmentĀ [5].


Epidemiology

Fungal infections represent a major global disease burden:

  • Chronic pulmonary aspergillosis:Ā ~3 million cases annually

  • Cryptococcal meningitis (HIV/AIDS-related):Ā ~223,100 cases and 181,000 deaths per year, mainly in sub-Saharan Africa

  • Invasive candidiasis:Ā ~700,000 cases

  • Invasive aspergillosis:Ā ~250,000 cases

  • Histoplasmosis:Ā ~100,000 cases

  • Fungal asthma:Ā ~10 million cases worldwide [1]

  • Pneumocystis pneumonia:Ā >400,000 deaths yearly in untreated patients


Emerging Threats and Medical Context

Systemic fungal infections were rare before the 1950s, but modern medicine has created new opportunities for fungi to infect vulnerable hosts.Risk factors include:

  • Antibiotic use

  • Intensive care unit (ICU) treatment

  • Immunosuppressive therapy

  • Chemotherapy

Mortality rates for invasive fungal infections remain high — 30–90%, depending on the pathogen and patient group [6].


Superficial and Invasive Infections

Superficial infections:Affect skin, hair, and nails, impacting over 1 billion peopleĀ worldwide.

Mucosal infections:Candida species causing oral or vaginal candidiasis.

Chronic subcutaneous infections:Include mycetomaĀ and chromoblastomycosis, classified as neglected tropical diseases.

Chronic pulmonary fungal infections:Often develop as complications of tuberculosisĀ or other chronic lung diseases.

Fungal allergies:Contribute to worsening of asthma, cystic fibrosis, and chronic sinusitis.

Invasive fungal infections:Life-threatening, requiring rapid diagnosis and targeted antifungal therapy.


Common Fungal Infections in Humans

  • Aspergillosis:Ā Severe lung infection in immunocompromised individuals.

  • Blastomycosis:Ā Primarily pulmonary, may spread to skin and bones.

  • Candida albicans:Ā Causes oral, vaginal, and systemic infections.

  • Chromoblastomycosis:Ā Chronic skin/subcutaneous infection, tropical or subtropical regions.

  • Coccidioidomycosis:Ā Pulmonary infection with fever and rash, common in the USA and Mexico.

  • Cryptococcosis:Ā Lung and CNS infection in AIDS patients.

  • Tinea pedis (athlete’s foot):Ā Common superficial fungal infection.

  • Histoplasmosis:Ā Acute flu-like or chronic, potentially fatal lung infection.

  • Mucormycosis:Ā Aggressive opportunistic infection.

  • Onychomycosis:Ā Nail fungus, common in elderly and diabetic individuals.

  • Paracoccidioidomycosis:Ā Endemic in South and Central America.

  • Pneumocystis pneumonia:Ā AIDS-related, fatal if untreated.

  • Sporotrichosis:Ā Chronic skin infection (ā€œrose gardener’s diseaseā€).

  • Tinea versicolor/cruris:Ā Superficial skin infections, common in tropical climates [7][8].


Conclusion

Fungal diseasesĀ represent a major yet underestimated global health challenge. Their chronic progression, complex pathogenesis, and high mortality ratesĀ in invasive cases demand greater attention from public health systems.Improved diagnostic tools, access to antifungal therapies, and vaccine developmentĀ (where possible) are critical steps toward reducing global fungal disease burden.


References:

  1. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. Journal of fungi. 2017 Dec;3(4):57.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753159/

  2. McKeny PT, Zito PM. Antifungal Antibiotics.2020 :https://www.ncbi.nlm.nih.gov/books/NBK538168/

  3. Healthline Fungal Infections :https://www.healthline.com/health/fungal-infection#types

  4. Casadevall A. Fungal diseases in the 21st century: the near and far horizons. Pathogens & immunity. 2018;3(2):183.:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241320/

  5. Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS neglected tropical diseases. 2020 Feb 20;14(2):e0007964 :.https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007964

  6. Fisher MC, Gurr SJ, Cuomo CA, Blehert DS, Jin H, Stukenbrock EH, Stajich JE, Kahmann R, Boone C, Denning DW, Gow NA. Threats posed by the Fungal Kingdom to humans, wildlife, and agriculture. mBio. 2020 Jun 30;11(3).:https://mbio.asm.org/content/11/3/e00449-20#sec-2

  7. Gupta AK, Ricci MJ. Diagnosing onychomycosis. Dermatol Clin. 2006;24(3):365–9.

  8. The free dictionary Available from:https://medical-dictionary.thefreedictionary.com/sporotrichosis

Tip: Use Ctrl + F to search on the page.

Help us keep PhysioDock free

All content on PhysioDock is free – but it costs to keep it running.

​

PhysioDock is built to be an open and accessible platform for physiotherapists, students, and patients alike. Here you’ll find articles, measurement tools, exercise libraries, diagnostic resources, and professional materials – all completely free.

Behind the scenes, however, there are hundreds of hours of work: research, writing, development, design, maintenance, testing, and updates. We do this because we believe in open knowledge and better health information.

​

If you’d like to support our work and help us continue developing and improving PhysioDock, we truly appreciate everyone who:
– subscribes to a PhysioDock+ membership
– uses and recommends PhysioDock in their work or studies
– shares PhysioDock with others

​

Every contribution makes a difference – and helps us keep the platform open to everyone.
Thank you for supporting PhysioDock!

Best value

PhysioDock+

NOKĀ 199

199

Every month

PhysioDock+ gives you exclusive benefits such as discounts, AI tools, and professional resources. The membership helps you work more efficiently, stay updated, and save time and money in your daily practice.

Valid until canceled

Access to Fysio-Open

Physionews+

Quizzes

10% discount on all purchases

5% discount on "Website for Your Clinic"

50% discount on shipping

Access to PhysioDock-AI (Under development)

Partner discounts

Exclusive product discounts

Contact us

Is something incorrect?

Something missing?
Something you’d like to see added?
More recent literature?

Feel free to get in touch and let us know which article it concerns and what could be improved.
We truly appreciate your feedback!

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for contributing!

bottom of page